de la Torre BG, Albericio F. The pharmaceutical industry in 2020: an analysis of FDA drug approvals from the perspective of molecules. Molecules. 2021;26:627.
Zhang C, Ötjengerdes RM, Roewe J, Mejias R, Marschall ALJ. Applying antibodies inside cells: principles and recent advances in neurobiology, virology and oncology. BioDrugs. 2020. https://doi.org/10.1007/s40259-020-00419-w.
Marschall ALJ, Dübel S, Böldicke T. Specific in vivo knockdown of protein function by intrabodies. MAbs. 2015;7:1010–35.
Marschall ALJ, Dübel S. Antibodies inside of a cell can change its outside: can intrabodies provide a new therapeutic paradigm? Comput Struct Biotechnol J. 2016;14:304–8.
Stewart MP, Langer R, Jensen KF. Intracellular delivery by membrane disruption: mechanisms, strategies, and concepts. Chem Rev. 2018;118:7409–531.
Marschall ALJ. Targeting the inside of cells with biologicals: chemicals as a delivery strategy. BioDrugs Clin Immunother Biopharm Gene Ther. 2021;35:1–29.
Guillard S, Minter RR, Jackson RH. Engineering therapeutic proteins for cell entry: the natural approach. Trends Biotechnol. 2015;33:163–71.
Wernick NLB, Chinnapen DJ-F, Cho JA, Lencer WI. Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum. Toxins. 2010;2:310–25.
Bagola K, Mehnert M, Jarosch E, Sommer T. Protein dislocation from the ER. Spec Sect Protein Translocat Inser Membr. 2011;1808:925–36.
Spooner RA, Lord JM. How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr Top Microbiol Immunol. 2012;357:19–40. https://doi.org/10.1007/82_2011_154.
Spooner RA, Lord JM. Ricin trafficking in cells. Toxins. 2015;7:49–65.
Teter K. Intracellular trafficking and translocation of pertussis toxin. Toxins. 2019;11:437.
Ruggiano A, Foresti O, Carvalho P. ER-associated degradation: protein quality control and beyond. J Cell Biol. 2014;204:869–79.
Teter K, Holmes RK. Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin. Infect Immun. 2002;70:6172–9.
Michalska M, Wolf P. Pseudomonas exotoxin A: optimized by evolution for effective killing. Front Microbiol. 2015;6:963–963.
Teter K, Allyn RL, Jobling MG, Holmes RK. Transfer of the cholera toxin A1 polypeptide from the endoplasmic reticulum to the cytosol is a rapid process facilitated by the endoplasmic reticulum-associated degradation pathway. Infect Immun. 2002;70:6166–71.
LaPointe P, Wei X, Gariépy J. A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen*. J Biol Chem. 2005;280:23310–8.
Li S, Spooner RA, Hampton RY, Lord JM, Roberts LM. Cytosolic entry of Shiga-like toxin A chain from the yeast endoplasmic reticulum requires catalytically active Hrd1p. PLoS ONE. 2012;7: e41119.
Chan YS, Ng TB. Shiga toxins: from structure and mechanism to applications. Appl Microbiol Biotechnol. 2016;100:1597–610.
Simpson JC, Roberts LM, Romisch K, Davey J, Wolf DH, Lord JM. Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast. FEBS Lett. 1999;459:80–4.
Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, O’Brien AD, et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun. 1993;61:3392–402.
Itoh K, Tezuka T, Inoue K, Tada H, Suzuki T. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide. Tohoku J Exp Med. 2001;195:237–43.
Sandvig K, van Deurs B. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin. FEBS Lett. 2002;529:49–53.
Pfeffer SR. Multiple routes of protein transport from endosomes to the trans Golgi network. Golgi Complex. 2009;583:3811–6.
Li D, Selyunin A, Mukhopadhyay S. Targeting the early endosome-to-Golgi transport of Shiga toxins as a therapeutic strategy. Toxins. 2020;12:342.
Sandvig K, Kavaliauskiene S, Skotland T. The protein toxins ricin and Shiga toxin as tools to explore cellular mechanisms of internalization and intracellular transport. Toxins. 2021;13:377.
Chaudhary VK, Jinno Y, FitzGerald D, Pastan I. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc Natl Acad Sci. 1990;87:308–12.
Majoul IV, Bastiaens PI, Söling HD. Transport of an external Lys-Asp-Glu-Leu (KDEL) protein from the plasma membrane to the endoplasmic reticulum: studies with cholera toxin in Vero cells. J Cell Biol. 1996;133:777–89.
Hessler JL, Kreitman RJ. An early step in Pseudomonas exotoxin action is removal of the terminal lysine residue, which allows binding to the KDEL receptor. Biochemistry. 1997;36:14577–82.
Tarragó-Trani MT, Storrie B. Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum. Adv Drug Deliv Rev. 2007;59:782–97.
Wales R, Chaddock JA, Roberts LM, Lord JM. Addition of an ER retention signal to the ricin A chain increases the cytotoxicity of the holotoxin. Exp Cell Res. 1992;203:1–4.
Wales R, Roberts LM, Lord JM. Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells. J Biol Chem. 1993;268:23986–90.
Johannes L, Tenza D, Antony C, Goud B. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin. J Biol Chem. 1997;272:19554–61.
Jackson ME, Simpson J, Girod A, Pepperkok R, Roberts L, Lord JM. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J Cell Sci. 1999;112(Pt 4):467–75.
Girod A, Storrie B, Simpson J, Johannes L, Roberts L, Lord J, et al. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat Cell Biol. 1999;1:423–30.
Lencer WI, Constable C, Moe S, Jobling MG, Webb HM, Ruston S, et al. Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL. J Cell Biol. 1995;131:951–62.
Garred Ø, van Deurs B, Sandvig K. Furin-induced cleavage and activation of Shiga toxin*. J Biol Chem. 1995;270:10817–21.
Garred Ø, Dubinina E, Polesskaya A, Olsnes S, Kozlov J, Sandvig K. Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells *. J Biol Chem. 1997;272:11414–9.
Yu M, Haslam DB. Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3. Infect Immun. 2005;73:2524–32.
Hazes B, Read RJ. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry. 1997;36:11051–4.
Wesche J, Rapak A, Olsnes S. Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol *. J Biol Chem. 1999;274:34443–9.
Schmitz A, Herrgen H, Winkeler A, Herzog V. Cholera toxin is exported from microsomes by the Sec61p complex. J Cell Biol. 2000;148:1203–12.
Bernardi KM, Forster ML, Lencer WI, Tsai B. Derlin-1 facilitates the retro-translocation of cholera toxin. Mol Biol Cell. 2008;19:877–84.
Bernardi KM, Williams JM, Kikkert M, van Voorden S, Wiertz EJ, Ye Y, et al. The E3 ubiquitin ligases Hrd1 and gp78 bind to and promote cholera toxin retro-translocation. Mol Biol Cell. 2010;21:140–51.
Veithen A, Raze D, Locht C. Intracellular trafficking and membrane translocation of pertussis toxin into host cells. Int J Med Microbiol. 2000;290:409–13.
Pande AH, Moe D, Jamnadas M, Tatulian SA, Teter K. The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome. Biochemistry. 2006;45:13734–40.
留言 (0)